Below is a clinical overview of the GHK-Cu peptide, covering mechanisms, dosing, safety, and comparisons
An eight-week open-label trial involving children aged 313 years with autism revealed that oral lipoceutical glutathione supplementation resulted in significant increases in plasma-reduced glutathione levels
Additionally, the peptide might have reactivated the apoptosis pathway, a type of programmed cell death crucial for removing faulty cells, as evidenced by activity in caspases 3 and 7, which are enzymes that play key roles in apoptosis
BPC-157 upregulates growth hormone receptors on fibroblasts (the cells that produce collagen)
For Consultations: A $50 deposit is required, forfeited for cancellations or no-shows within 24 hours
Helps reduce pigmentation & dark spots